<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_Losers_Strategies_For_PF-06463922_Described</id>
		<title>The Losers Strategies For PF-06463922 Described - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_Losers_Strategies_For_PF-06463922_Described"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_Losers_Strategies_For_PF-06463922_Described&amp;action=history"/>
		<updated>2026-07-07T20:09:45Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=The_Losers_Strategies_For_PF-06463922_Described&amp;diff=45387&amp;oldid=prev</id>
		<title>Brianoffice0 : Page créée avec « Because Aeromonas are ubiquitous in a wide range of environments, they might act as important vectors for the transfer of plasmid-mediated quinolone resistance [14]. The [... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_Losers_Strategies_For_PF-06463922_Described&amp;diff=45387&amp;oldid=prev"/>
				<updated>2016-12-06T10:35:35Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « Because Aeromonas are ubiquitous in a wide range of environments, they might act as important vectors for the transfer of plasmid-mediated quinolone resistance [14]. The [... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Because Aeromonas are ubiquitous in a wide range of environments, they might act as important vectors for the transfer of plasmid-mediated quinolone resistance [14]. The [http://en.wikipedia.org/wiki/FMO5 FMO5] authors declare that they have no conflicts of interest in relation to this work. &amp;quot;&amp;quot;Clin Microbiol Infect 2011; 17: 1538�C1545 The risk factors and clinical features of patients with Candida tropicalis fungaemia have not been fully defined. We performed a case�Ccontrol study comparing 59 cases of C.?tropicalis fungaemia with 177 episodes of fungaemia caused by other species of Candida in our hospital over a 24-year period (January 1985 to December 2008). Patients with C.?tropicalis fungaemia were more likely to be older (median age, 67 vs. 56?years; p?0.01), to have cancer (45.5% vs. 31.6%, p?0.04), and to have the abdomen as the portal of entry (32.2% vs. 11.9%, p?0.001), and had a higher in-hospital mortality rate (61% vs. 44%, p?0.03). Multivariate analysis showed that the independent risk factors for C.?tropicalis fungaemia were cancer (OR?4.5; 95%?CI?1.05�C3.83; p?0.03) and the abdomen as the portal of entry (OR?13.6; 95%?CI?1.9�C8.2; p?[http://www.selleckchem.com/products/Bafilomycin-A1.html Bafilomycin A1 datasheet] p?0.03) and catheter removal (OR?0.06; 95%?CI?0.01�C0.4; p?0.002) were protective factors. C.?tropicalis is the fourth most common cause of fungaemia in our hospital. It is associated with underlying malignancy, the abdomen as the [http://www.selleckchem.com/products/pf-06463922.html PF-06463922 mw] portal of entry, and poor outcome. Candidaemia is a major cause of morbidity and mortality in the healthcare setting. Candida species now rank fourth in the USA and sixth in Europe among causes of nosocomial bloodstream infection (BSI) [1�C3]. In addition, the crude mortality rate of candidaemia is approximately 40�C50%, depending on the population and the species studied [4�C6]. In recent years, there has been an increase in the incidence of candidaemia and a shift towards Candida species other than Candida albicans, with Candida parapsilosis, Candida glabrata, Candida krusei and Candida tropicalis causing almost half of all episodes [5�C12]. C.?parapsilosis has been related to overuse of venous catheters, especially in neonates, transplant recipients, and patients receiving parenteral nutrition [13]. The emergence of C.?glabrata and C.?krusei has been related to antifungal exposure in specific populations, such as elderly patients, solid organ recipients, patients with neutropenia, patients receiving corticosteroids, and neonates [5].&lt;/div&gt;</summary>
		<author><name>Brianoffice0</name></author>	</entry>

	</feed>